| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34fbcff83218187bec435a4fade23f9d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84d18216288235d24f351156ee94b0d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d200efdd6d0e8bfc8bebe467ff5f7984
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4637a5fdad633a564683619b2eb99d75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_572f02132a7ea456a67cad7201280199 |
| publicationDate |
2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160013770-A |
| titleOfInvention |
Novel crystalline complex of dapagliflozin and method for preparing same |
| abstract |
The present invention relates to a D-mannitol complex of daraglyphrozin, which is an SGLT2 inhibitor, and a process for producing the same. The present invention relates to a novel D-mannitol D-mannitol crystalline hydrate complex of the present invention which is less expensive than a conventional (S) , And has a higher antidiabetic effect. |
| priorityDate |
2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |